Abstract
Following the outbreak of haemolytic uraemic syndrome (HUS) on June 2011 in south-western France, household transmission due to Escherichia coli O104:H4 was suspected for two cases who developed symptoms 9 and 10 days after onset of symptoms of the index case. The analysis of exposures and of the incubation period is in favour of a secondary transmission within the family. Recommendations should be reinforced to prevent person-to-person transmission within households.
MeSH terms
-
Abdominal Pain / etiology
-
Adult
-
Anti-Bacterial Agents / therapeutic use
-
Cephalosporins / therapeutic use
-
Child, Preschool
-
Contact Tracing
-
Diarrhea / complications
-
Diarrhea / epidemiology
-
Disease Outbreaks
-
Escherichia coli / classification
-
Escherichia coli / genetics
-
Escherichia coli / isolation & purification*
-
Escherichia coli Infections / complications
-
Escherichia coli Infections / drug therapy
-
Escherichia coli Infections / epidemiology
-
Escherichia coli Infections / transmission*
-
Family Characteristics
-
Feces / microbiology
-
France / epidemiology
-
Hemolytic-Uremic Syndrome / complications
-
Hemolytic-Uremic Syndrome / drug therapy
-
Hemolytic-Uremic Syndrome / epidemiology
-
Hemolytic-Uremic Syndrome / microbiology*
-
Humans
-
Male
-
Shiga-Toxigenic Escherichia coli / drug effects
-
Shiga-Toxigenic Escherichia coli / genetics
-
Shiga-Toxigenic Escherichia coli / isolation & purification*
-
Treatment Outcome
Substances
-
Anti-Bacterial Agents
-
Cephalosporins